You haven't searched anything yet.
About Celularity Inc.
Celularity Inc., headquartered in Florham Park, N.J ., is a biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. Celularity is developing a pipeline of off-the-shelf placental-derived allogeneic cell therapy product candidates including T cells engineered with a chimeric antigen receptor ("CAR"), natural killer ("NK") cells, and mesenchymal-like adherent stromal cells ("MLASCs") and exosomes. These therapeutic candidates target indications across cancer, infectious, and degenerative diseases. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address a significant unmet global need for effective, accessible, and affordable therapeutics.
Summary:
Celularity is seeking a dynamic individual to join a motivated team of clinical operators for the daily manufacture of multiple tissue product. Leveraging Celularity’s new, state-of-the-art cGMP capable facility, this position will make use of existing innovations and future technologies to meet and exceed manufacturing demand.
Role and Responsibilities not limited to:
Minimum Qualifications (Must have)
Preferred Qualifications
Working Conditions
Celularity Inc. is an equal opportunity employer
Full Time
$67k-86k (estimate)
06/10/2024
06/23/2024
celularity.com
FLORHAM PARK, NJ
100 - 200
2016
ROBERT HARIRI
$50M - $200M
Pharmaceutical
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics. Celularitys innovative approach to cell therapy harnesses the unique therapeutic potential locked within the postpartum placenta. Through natures immunotherapy engine the placenta Celularity is leading the next evolution of cellular medicine with placenta-derived T cells, NK cells, and pluripotent stem cells to target unmet and underser ...
ved clinical needs in cancer, infectious and degenerative diseases. To learn more visit celularity.com.
More
Show Less